Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 23462681)

  • 1. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.
    Pleijhuis RG; Kwast AB; Jansen L; de Vries J; Lanting R; Bart J; Wiggers T; van Dam GM; Siesling S
    Breast; 2013 Oct; 22(5):773-9. PubMed ID: 23462681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram for predicting positive resection margins after breast-conserving surgery.
    Shin HC; Han W; Moon HG; Cho N; Moon WK; Park IA; Park SJ; Noh DY
    Breast Cancer Res Treat; 2012 Aug; 134(3):1115-23. PubMed ID: 22692386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of positive margins following breast conserving surgery.
    Agostinho JL; Zhao X; Sun W; Laronga C; Kiluk JV; Chen DT; Lee MC
    Breast; 2015 Feb; 24(1):46-50. PubMed ID: 25466503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive margins prediction in breast cancer conservative surgery: Assessment of a preoperative web-based nomogram.
    Alves-Ribeiro L; Osório F; Amendoeira I; Fougo JL
    Breast; 2016 Aug; 28():167-73. PubMed ID: 27326978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation and modification of nomogram for predicting positive resection margins before breast conserving surgery.
    Jung JJ; Kang E; Kim EK; Kim SM; Jang M; La Yun B; Park SY; Shin HC
    Breast Cancer Res Treat; 2020 Sep; 183(2):373-380. PubMed ID: 32647937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
    Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
    Wang F; Li H; Tan PH; Chua ET; Yeo RM; Lim FL; Kim SW; Tan DY; Wong FY
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):684-91. PubMed ID: 25194727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of margin status on local recurrence following breast conserving therapy for invasive carcinoma in Manitoba.
    Hardy K; Fradette K; Gheorghe R; Lucman L; Latosinsky S
    J Surg Oncol; 2008 Nov; 98(6):399-402. PubMed ID: 18767118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast.
    Lee SK; Yang JH; Woo SY; Lee JE; Nam SJ
    Br J Surg; 2013 Dec; 100(13):1756-63. PubMed ID: 24227361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of positive resection margins in patients with non-palpable breast cancer.
    Barentsz MW; Postma EL; van Dalen T; van den Bosch MA; Miao H; Gobardhan PD; van den Hout LE; Pijnappel RM; Witkamp AJ; van Diest PJ; van Hillegersberg R; Verkooijen HM
    Eur J Surg Oncol; 2015 Jan; 41(1):106-12. PubMed ID: 25228054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting local recurrence following breast-conserving treatment: parenchymal signal enhancement ratio (SER) around the tumor on preoperative MRI.
    Kim MY; Cho N; Koo HR; Yun BL; Bae MS; Chie EK; Moon WK
    Acta Radiol; 2013 Sep; 54(7):731-8. PubMed ID: 23550189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
    Witteveen A; Vliegen IM; Sonke GS; Klaase JM; IJzerman MJ; Siesling S
    Breast Cancer Res Treat; 2015 Aug; 152(3):627-36. PubMed ID: 26162567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?
    Sadek BT; Shenouda MN; Abi Raad RF; Niemierko A; Keruakous AR; Goldberg SI; Taghian AG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):726-30. PubMed ID: 24064317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Russo AL; Arvold ND; Niemierko A; Wong N; Wong JS; Bellon JR; Punglia RS; Golshan M; Troyan SL; Brock JE; Harris JR
    Breast Cancer Res Treat; 2013 Jul; 140(2):353-61. PubMed ID: 23836011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
    Sweldens C; Peeters S; van Limbergen E; Janssen H; Laenen A; Patil S; Van Zee KJ; Weltens C
    Cancer J; 2014; 20(1):1-7. PubMed ID: 24445756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy.
    Lupe K; Truong PT; Alexander C; Lesperance M; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e561-8. PubMed ID: 21514069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience.
    Barbieri V; Sanpaolo P; Genovesi D
    Clin Breast Cancer; 2011 Apr; 11(2):114-20. PubMed ID: 21569997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.